Pfizer-BioNTech’s new bivalent Covid-19 vaccine—which targets the original strain and some Omicron subvariants—provides more protection against the virus and its omicron variants than its initial vaccine, according to a study released Friday.
Subscribe to:
Post Comments (Atom)
< + > Stop Waiting on Mandates: CMS Challenges Health IT to Act Now
“We’re the government and we’re here to help.” That’s a common punchline, but based on recent IT announcements from CMS, this line may turn ...
No comments:
Post a Comment